Platelet reactivity on aspirin, clopidogrel and abciximab in patients with acute coronary syndromes and reduced estimated glomerular filtration rate

Thromb Res. 2010 Jan;125(1):67-71. doi: 10.1016/j.thromres.2009.03.015. Epub 2009 May 13.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abciximab
  • Acute Coronary Syndrome / drug therapy*
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use
  • Aspirin / therapeutic use
  • Blood Platelets / drug effects
  • Clopidogrel
  • Drug Therapy, Combination
  • Female
  • Glomerular Filtration Rate / drug effects*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Male
  • Middle Aged
  • Platelet Activation / drug effects*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin
  • Abciximab